At a glance
ClinicalIndex Comparison RecordN/ACompleted· 2,349 enrolled
Drug / intervention
Endeavor Resolute Zotarolimus-Eluting Coronary Stent Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
RESOLUTE International Registry: Evaluation of the Resolute Zotarolimus-Eluting Stent System in a 'Real-World' Patient Population
In Brief
An observational study evaluating Endeavor Resolute Zotarolimus-Eluting Coronary Stent System for Coronary Artery Disease and Cardiovascular Diseases. Completed, enrolled 2,349 participants across 1 site.
Detailed Summary
The primary objective of the RESOLUTE international registry is to document the safety and overall clinical performance of the Resolute Zotarolimus-Eluting Coronary Stent System in a 'real-world' patient population requiring stent implantation.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Artery Disease, Cardiovascular Diseases
CountriesGermany
CollaboratorsMedtronic Cardiac Rhythm and Heart Failure
Timeline
N/ACompletedFinished
2009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 2008
First PostedSep 2008
Primary CompletionOct 2010
Study CompletionDec 2012
TodayJul 2026
First PostedSep 15, 2008
Enrollment StartAug 1, 2008
Primary CompletionOct 1, 2010
Study CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 17.8 years ago
Interventions
Endeavor Resolute Zotarolimus-Eluting Coronary Stent Systemdevice
Stent implantation